Sandra Bedrosian‐Sermone

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndrome”.

An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndrome

Human Genetics and Genomics Advances(2022)10.1016/j.xhgg.2022.100138

N/A

0DataRank · unranked

20 citations

Tess Levy, Sarah B. Barkley, Sandra Bedrosian‐Sermone, Matthew M. Davis, Jennifer H. Foss‐Feig +14 more

Development of informant‐report neurobehavioral survey scales for PTEN hamartoma tumor syndrome and related neurodevelopmental genetic syndromes

American Journal of Medical Genetics Part A(2023)10.1002/ajmg.a.63195

N/A

0DataRank · unranked

16 citations

Robyn M. Busch, Patricia Klaas, Katherine Lachlan, Shafali Jeste, A lexander Kolevzon +15 more

Remote monitoring of social attention in neurogenetic syndromes and idiopathic neurodevelopmental disability

Autism Research(2024)10.1002/aur.3290

N/A

0DataRank · unranked

4 citations

Robyn M. Busch, Patricia Klaas, Katherine Lachlan, Shafali Jeste, A lexander Kolevzon +16 more